NAD+ : What the Research Shows
A research-audience overview of NAD+, a central metabolic coenzyme studied in laboratory energy and cell-biology models. Research use only.
Read article
Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and SR-9009 is not approved for human or veterinary use.
SR-9009 (Stenabolic) is a synthetic compound studied in the research literature as an agonist of the REV-ERB proteins, which are part of the circadian-clock and metabolic-regulation machinery. It is a common subject in circadian-biology and metabolism research.
The evidence base is preclinical, based on cell and animal studies. Notably, its oral bioavailability is reported to be low, which is an important consideration in interpreting the research. Laboratory findings should not be extrapolated to people.
SR-9009 is not an approved medicinal product and appears on the World Anti-Doping Agency prohibited list. These points make its research-only status especially important.
SR-9009 is supplied strictly for laboratory and scientific research and is not for human or veterinary consumption.
It is studied as a REV-ERB agonist affecting circadian-clock and metabolic gene pathways in laboratory models.
No. It is not approved as a medicine and is banned in sport by WADA. It is a research material only.
SR-9009 (Stenabolic) is a REV-ERB agonist studied in circadian and metabolic research, with important regulatory caveats. It is a research material only. Review the SR-9009 research product.
Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.
A research-audience overview of NAD+, a central metabolic coenzyme studied in laboratory energy and cell-biology models. Research use only.
Read articleA research-audience overview of Glutathione, a naturally occurring tripeptide antioxidant studied in laboratory redox models. Research use only.
Read articleA research-audience overview of FOXO4-DRI, a designed peptide studied in laboratory senescence and senolytic research. Research use only.
Read article